Efficacy and safety of once-weekly dulaglutide versus insulin glargine in mainly Asian patients with type 2 diabetes mellitus on metformin and/or a sulphonylurea: A 52-week open-label, randomized phase III trial
- Weiqing Wang
- , Luis Nevárez
- , Ekaterina Filippova
- , Ki Ho Song
- , Bei Tao
- , Liqun Gu
- , Feng Wang
- , Pengfei Li
- , Jun Yang
- Shanghai Jiao Tong University
- Hospital Angeles
- LLC
- Lilly Suzhou Pharmaceutical Company Ltd
Research output: Contribution to journal › Article › peer-review
55
Scopus
citations